167 related articles for article (PubMed ID: 25962872)
1. Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.
Zhang L; Zhang Z; Mason RP; Sarkaria JN; Zhao D
Sci Rep; 2015 May; 5():9874. PubMed ID: 25962872
[TBL] [Abstract][Full Text] [Related]
2. Real-time monitoring of arsenic trioxide release and delivery by activatable T(1) imaging.
Zhao Z; Wang X; Zhang Z; Zhang H; Liu H; Zhu X; Li H; Chi X; Yin Z; Gao J
ACS Nano; 2015 Mar; 9(3):2749-59. PubMed ID: 25688714
[TBL] [Abstract][Full Text] [Related]
3. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared light-activated red-emitting upconverting nanoplatform for T
Tang XL; Wu J; Lin BL; Cui S; Liu HM; Yu RT; Shen XD; Wang TW; Xia W
Acta Biomater; 2018 Jul; 74():360-373. PubMed ID: 29763715
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine-targeted liposome for enhanced glioma-selective imaging.
Zhang L; Habib AA; Zhao D
Oncotarget; 2016 Jun; 7(25):38693-38706. PubMed ID: 27231848
[TBL] [Abstract][Full Text] [Related]
7. Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.
Tao J; Fei W; Tang H; Li C; Mu C; Zheng H; Li F; Zhu Z
Mol Pharm; 2019 Feb; 16(2):786-797. PubMed ID: 30620881
[TBL] [Abstract][Full Text] [Related]
8. An extracellular pH-driven targeted multifunctional manganese arsenite delivery system for tumor imaging and therapy.
Zhang K; Lin H; Mao J; Luo X; Wei R; Su Z; Zhou B; Li D; Gao J; Shan H
Biomater Sci; 2019 May; 7(6):2480-2490. PubMed ID: 30957825
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
Kumthekar P; Grimm S; Chandler J; Mehta M; Marymont M; Levy R; Muro K; Helenowski I; McCarthy K; Fountas L; Raizer J
J Neurooncol; 2017 Jul; 133(3):589-594. PubMed ID: 28510787
[TBL] [Abstract][Full Text] [Related]
10. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells.
Zhang Q; Vakili MR; Li XF; Lavasanifar A; Le XC
Biomaterials; 2014 Aug; 35(25):7088-100. PubMed ID: 24840615
[TBL] [Abstract][Full Text] [Related]
11. Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy.
Zhai Y; Liu M; Yang T; Luo J; Wei C; Shen J; Song X; Ke H; Sun P; Guo M; Deng Y; Chen H
J Control Release; 2022 Oct; 350():761-776. PubMed ID: 36063961
[TBL] [Abstract][Full Text] [Related]
12. Lethal drug combination: arsenic loaded multiple drug mesoporous silica for theranostic applications.
Muhammad F; Zhao J; Wang N; Guo M; Wang A; Chen L; Guo Y; Li Q; Zhu G
Colloids Surf B Biointerfaces; 2014 Nov; 123():506-14. PubMed ID: 25448719
[TBL] [Abstract][Full Text] [Related]
13. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
14. Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release.
Chen H; MacDonald RC; Li S; Krett NL; Rosen ST; O'Halloran TV
J Am Chem Soc; 2006 Oct; 128(41):13348-9. PubMed ID: 17031934
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis.
Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956
[TBL] [Abstract][Full Text] [Related]
17. Manganese-Based Layered Double Hydroxide Nanoparticles as a T
Li B; Gu Z; Kurniawan N; Chen W; Xu ZP
Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28585312
[TBL] [Abstract][Full Text] [Related]
18. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
19. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
Huang CC; Khu NH; Yeh CS
Biomaterials; 2010 May; 31(14):4073-8. PubMed ID: 20149451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
